文献速递青光眼

奈他舒地尔通过多种机制增加人眼房水流出易度

Netarsudil Increases Outflow Facility in Human Eyes Through Multiple Mechanisms.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2016-01-01

研究者在离体人眼中灌注奈他舒地尔活性代谢物奈他舒地尔-M1或溶媒,发现其显著增加房水流出易度,并增加小梁网内壁和巩膜外静脉的有效滤过长度,同时扩张巩膜外静脉、增厚近管结缔组织。

要点

  • 奈他舒地尔-M1使离体人眼房水流出易度较基线增加51%(P<0.01),较配对对照增加102%(P<0.01)。
  • 奈他舒地尔-M1增加小梁网内壁(P<0.05)和巩膜外静脉(P<0.01)的有效滤过长度百分比。
  • 巩膜外静脉有效滤过长度与房水流出易度变化百分比正相关(R2=0.58,P=0.01)。

核心结论

  • 奈他舒地尔通过扩张近管结缔组织和扩张巩膜外静脉急性增加房水流出易度,使房水流出重新分布到更大面积的小梁网内壁和巩膜外静脉。

研究设计与样本

  • 离体人眼配对研究,共5对眼,灌注0.3 μM奈他舒地尔-M1或溶媒溶液,恒压15 mm Hg,3小时后加入荧光微球追踪流出模式。

主要发现

  • 灌注奈他舒地尔-M1眼房水流出易度较基线增加51%(P<0.01),较配对对照眼增加102%(P<0.01)。
  • 奈他舒地尔-M1眼小梁网内壁有效滤过长度百分比较对照显著增加(P<0.05),巩膜外静脉有效滤过长度百分比较对照显著增加(P<0.01)。
  • 奈他舒地尔-M1眼巩膜外静脉有效滤过长度百分比显著高于小梁网内壁(P<0.01),并与巩膜外静脉横截面积增加相关(P<0.01)。
  • 巩膜外静脉有效滤过长度百分比与房水流出易度变化百分比正相关(R2=0.58,P=0.01)。
  • 奈他舒地尔-M1眼近管结缔组织厚度较对照眼显著增加(P<0.05)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Netarsudil is a Rho kinase/norepinephrine transporter inhibitor currently in phase 3 clinical development for glaucoma treatment. We investigated the effects of its active metabolite, netarsudil-M1, on outflow facility (C), outflow hydrodynamics, and morphology of the conventional outflow pathway in enucleated human eyes. METHODS: Paired human eyes (n = 5) were perfused with either 0.3 μM netarsudil-M1 or vehicle solution at constant pressure (15 mm Hg). After 3 hours, fluorescent microspheres were added to perfusion media to trace the outflow patterns before perfusion-fixation. The percentage effective filtration length (PEFL) was calculated from the measured lengths of tracer distribution in the trabecular meshwork (TM), episcleral veins (ESVs), and along the inner wall (IW) of Schlemm's canal after global and confocal imaging. Morphologic changes along the trabecular outflow pathway were investigated by confocal, light, and electron microscopy. RESULTS: Perfusion with netarsudil-M1 significantly increased C when compared to baseline (51%, P < 0.01) and to paired controls (102%, P < 0.01), as well as significantly increased PEFL in both IW (P < 0.05) and ESVs (P < 0.01). In treated eyes, PEFL was significantly higher in ESVs than in the IW (P < 0.01) and was associated with increased cross-sectional area of ESVs (P < 0.01). Percentage effective filtration length in ESVs positively correlated with the percentage change in C (R2 = 0.58, P = 0.01). A significant increase in juxtacanalicular connective tissue (JCT) thickness (P < 0.05) was found in treated eyes compared to controls. CONCLUSIONS: Netarsudil acutely increased C by expansion of the JCT and dilating the ESVs, which led to redistribution of aqueous outflow through a larger area of the IW and ESVs.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Ren R, Li G, Le TD, et al. Netarsudil Increases Outflow Facility in Human Eyes Through Multiple Mechanisms. Invest Ophthalmol Vis Sci. 2016. PMID: 27842161. doi:10.1167/iovs.16-20189

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。